Rest After Spontaneous Breathing Trial for Prevention of Post-extubation Failure
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01915563 |
|
Recruitment Status :
Completed
First Posted : August 5, 2013
Results First Posted : July 1, 2019
Last Update Posted : July 1, 2019
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Weaning Failure | Procedure: REST | Not Applicable |
Intubation and mechanical ventilation are related with several complications. This increased the risk of mortality of intensive care patients. So, we always look for an early extubation when patients are recovered for the trigger disease. In spite of standardized manoeuvres to decided readiness for extubation these are not quite good because it has been described a failure extubation rate of 5% and a reintubation rate of 15%. Furthermore several risk factors has been associated with a major failure rate:>65 years old, congestive cardiac insufficiency, chronic obstructive pulmonary disease, APACHE II >12 the extubation day, BMI >30, ineffective cough, a lot of bronchial secretions (as the need for >2 endotracheal suctioning in the last 8h before extubation), failure of a previous SBT,alterations of high respiratory tract or intubation for more than 7 days.Patients without any of these factors risk has an extubation failure rate of 10% while if any of these are present extubation failure increase to 30%.
The most used technique as a weaning trial is named spontaneous breathing trial (SBT). Some physiological aspects suggest that breathing through an endotracheal tube could be a really effort trial. So our hypothesis is that a period of rest after SBT and before extubation could reduce the extubation failure rate.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 470 participants |
| Allocation: | Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Prevention |
| Official Title: | Phase 2 Study of 60-min Rest After Successful Spontaneous Breathing Trial Before Extubation as a Tool for Reduction Post-extubation Failure. |
| Actual Study Start Date : | September 2013 |
| Actual Primary Completion Date : | October 2014 |
| Actual Study Completion Date : | January 2015 |
| Arm | Intervention/treatment |
|---|---|
|
No Intervention: SBT and extubation
After a SBT patients will be extubated as usual
|
|
|
Experimental: SBT and rest 60 min before extubation
After SBT patients will be reconnected to mechanical ventilation during 60 min before extubation
|
Procedure: REST
After a SBT patients will be extubated as usual or reconnected to mechanical ventilation for 60 min before extubation. |
- Number of Patients With Extubation Failure [ Time Frame: 48 hours ]Development of predefined criteria of respiratory insufficiency within 48 hours after scheduled extubation
- ICU Mortality [ Time Frame: up to 3 months ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- patients ventilated for more than 12h and ready to perform a SBT
Exclusion Criteria:
- patients under 18 years old,
- tracheostomy,
- excessive bronchial secretions,
- agitation,
- hypercapnia during SBT and not resuscitation orders.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01915563
| Spain | |
| Hospitales: Mutua de Terrassa,Médico-quirúrgico Jaen, Morales Messeguer, General de Albacete, Lorca, Málaga, Santiago, General de Catalunya, Joan XXIII Tarragona, La Fe-Valencia, Bellvitge, Moises Broggi, Mateu Orfila, Reina Sofia, Severo-Ochoa, Delfos | |
| Terrassa, Barcelona, Spain, 08221 | |
| Principal Investigator: | Fernandez Rafael, MD, PhD | Althaia Xarxa Assistencial Universitària de Manresa | |
| Study Director: | Fernandez Maria del Mar, MD, PhD | Hospital Universitari Mutua de Terrassa |
| Responsible Party: | Rafael Fernandez, Head of Critical Care Department, Althaia Xarxa Assistencial Universitària de Manresa |
| ClinicalTrials.gov Identifier: | NCT01915563 |
| Other Study ID Numbers: |
SBT Spain 001 |
| First Posted: | August 5, 2013 Key Record Dates |
| Results First Posted: | July 1, 2019 |
| Last Update Posted: | July 1, 2019 |
| Last Verified: | April 2019 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | No |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Mechanical ventilation Weaning Extubation failure |
|
Respiratory Aspiration Respiration Disorders Respiratory Tract Diseases Pathologic Processes |

